Контроль над бронхиальной астмой: каким он будет завтра? Исследование GOAL

1. Первое издание на русском языке: Бронхиальная астма, глобальная стратегия. Основные направления лечения профилактики астмы: Всемирная организация здравоохранения. Национальный институт Сердца, Легких и Крови. Март 1993. Пульмонология 1996; Прил. 1: 1-165.

2. Barnes P.J., Pedersen S., Basse WAV. Efficacy and safety of inhaled corticosteroids: new developments. Am. J. Respir. Crit. Care Med. 1998; 157 (suppl.): S 1-S 53.

3. Lipworth B.J. Systemic adverse effects of inhaled corticosteroid therapy. Arch. Intern. Med. 1999; 159: 941-955. Asthma in America — www.asthmainamerica.com

4. Asthma insights reality in Europe — www.asthm aineurope.com

5. Juniper E.F., O'Byme P.M., Guyatt C.H. et al. Development and validation of a questionnaire to measure asthma control. Eur. Respir. J. 1999; 14: 902 - 907 .

6. Цой A.H., Демидова Г.В., Архипов В.В. Многоцентровое, сравнительное исследование эффективности и безопасности Симбикорта Турбухалер по сравнению с рутинной противоастматической терапией у больных со стабильным течением бронхиальной астмы. Пульмонология, 2004; 1: 83 - 88.

7. Gillissen A., Lecheler J. Corticophobia in asthma. Med. Klin. 2003; 98 (8 ): 417 -422 .

8. Цой A.H., Архипов В.В. Фармакоэпидемиологический анализ амбулаторной терапии бронхиальной астмы у взрослых и подростков в г. Москве в 2003 г. Consilium medicum 2004; 6 (4): 248-254.

9. Shrewsbury S., Pyke S., Britton M. Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA). Br. Med. J. 2000; 320: 1368-1379.

10. Woolcock A., Lundback B., Ringdal N., Jacques L.A. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am. J. Respir. Crit. Care Med. 1996; 153: 1481-1488.

11. Primatesta P., Brookes М., Poulter N.R. Improved hypertension management and control: results from the health survey for England 1998. Hypertension 2001; 38: 827-832.

12. Brown M.J., Cruickshank J.K., Dotniniczak A.F. et. al. Executive Committee British Hypertension Society. Better blood pressure control: how to combine drugs. J. Hum. Hypertens. 2003; 17: 81 -86.

13. Haahtela T., Jarvinnen М., Kava T. et. al. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N. Engl. J. Med. 1994; 331: 700-705.

14. Lemanske R.F . Jr., Sorkness C.A., Mauger E.A. et al. Inhaled corticosteroid reduction and elimination in patients with persistant asthma receiving salmeterol: a randomised controlled trial. J.A.M.A. 2001; 285: 2594-2603.

15. Hawkins G., McMahon A.D, Twaddle S.et al. Stepping down inhaled corticosteroids in asthma: randomised controlled trial. Br. Med. J. 2003 326: 1115.

16. British guideline on the management of asthma. A national clinical guideline. Thorax 2003; 58 (suppl. I): i 1 — 192.

17. Busse W., Baterman E., Boushey H. et al. Achieving G IN A /N IH guidelines based asthma control with salmeterol/fluticasone compared with fluticasone alone" the results of the GOAL study. J. A llergy Clin. Immunol. 2004; 1 13 (2, suppl. 1): SI 14.

18. Pauwels R., Baterman E., Boushey H. et al. Can total control of asthma be achieved?: the results of the GOAL study. J. Allergy Clin. Immunol. 2004; 113 (2, suppl. 1): SI 14.

19. Canadian asthma consensus report, 1999. Can. Med. Assoc. J. 1999; 161 (11, suppl.): 1-62.

20. Rabe et al. Eur. Respir. J. 2000; 16: 802 - 807 .

21. Kavuru et al. J. Allergy Clin. Immunol. 2000; 105: 1108 -1116 .

22. Ringdal et al. Respir. Med. 2002; 96: 8 5 1 -861.

23. Lundback et al. Respir. Med. 2000; 94: 724 -732 .

24. Nelson et al. J Allergy Clin. Immunol. 2000; 106: 1088 -1095 .

25. Pedersen S., Hansen O.R. Budesonide treatment of moderate and severe asthma in children: a dose-response study. J. Allergy Clin. Immunol. 1995; 95: 29 -33.

26. Alving K., Lundberg J.O.N., Nordvall S.L. Dose-dependent reduction of exhaled nitric oxide in asthmatic children by inhaled steroids (abstract). Am. J. Respir. Crit. Care Med. 1995; 151: Al 29.

27. Основные положения отчета группы экспертов EPR-2: ведущие направления в диагностике и лечении бронхиальной астмы. Национальный институт Сердца, Легких и Крови. NIH publication № 97-4051А. Май 1997: Пер. под ред. проф. А.Н. Цой. М.: Грантъ; 1998.

28. Gaining optimal asthma control: introducing the GOAL study. GOAL study Backgrounder, Glaxo Wellcom e Research & Development, nov. 2000.

29. NHLBI/WHO workshop report: global strategy for asthma management and prevention. NIH Publ. № 02-3659. Febr. 2002; 1-177.